Tatva Chintan Shares Surge 20% on Rs 200 Crore Expansion Plan
Mukul Mahavir Agrawal's notional one-day gain from Tatva Chintan Pharma Chem shares was Rs 14.28 crore after the stock hit a 20% upper circuit.
Tatva Chintan Pharma Chem announced a Rs 200 crore greenfield expansion at its Dahej-III facility, adding 344 KL reactor capacity over 21 months.
The stock surged 20% to Rs 1,713.70, with trading volumes of 21.7 lakh shares, well above its 30-day average of 1.21 lakh shares.
Mukul Mahavir Agrawal held 500,000 equity shares (2.14% stake) as of June 2026.
The stock has gained about 45% over the past four weeks following the expansion announcement.
Story angle
Center
Near the middle: closer to straight reporting, less party-line spin.
About how the story is framed, not whether the facts are true.
Dalal Street Investment Journal
Center
Mixed factuality
Who owns this?
DSIJ Pvt Ltd
Independent markets publisher